RSLBF OTC

RaySearch Laboratories AB (publ) is a global medical technology innovator, dedicated to developing advanced software solutions for cancer treatment. Its flagship product, RayStation, serves as a comprehensive treatment planning platform, integrating sophisticated features such as automated planning, adaptive therapy, multi-criteria optimization, and machine learning. This system ensures swift and precise dose calculations, minimizes exposure to organs-at-risk, and accommodates a wide spectrum of radiation modalities, from cutting-edge proton, carbon ion, and boron neutron capture therapies to conventional VMAT, IMRT, 3D-CRT, virtual simulation, electron beam, stereotactic, and tomotherapy treatments. Complementing this, RayPlan offers a specialized treatment planning system tailored for various conventional radiation therapy techniques, including 3D-CRT, IMRT, VMAT, tomotherapy, and electron beam. For streamlined clinical operations, RayCare provides an oncology information system designed to manage and support all facets of cancer treatment. The company also offers RayCommand, a treatment control system engineered for broad hardware compatibility and to leverage the advanced functionalities of treatment machinery. Furthermore, RayIntelligence is a cloud-based oncology analytics platform that transforms complex patient data into valuable, actionable insights. RaySearch also provides educational programs and training to facilitate optimal utilization of its software suite. The company maintains its primary operational base in Stockholm, Sweden.